metoclopramide

GPTKB entity

Statements (42)
Predicate Object
gptkbp:instanceOf gptkb:drug
dopamine antagonist
gptkbp:approvedInUS 1979
gptkbp:ATCCode A03FA01
gptkbp:brand gptkb:Maxolon
gptkb:Reglan
gptkbp:CASNumber 364-62-5
gptkbp:category antiemetic
prokinetic agent
gastroprokinetic
gptkbp:contraindication gptkb:pheochromocytoma
epilepsy
gastrointestinal hemorrhage
gptkbp:discoveredBy gptkb:Charles_Laville
gptkb:Justin-Besançon
gptkbp:discoveredIn 1964
gptkbp:eliminationHalfLife 5–6 hours
gptkbp:excretion urine
gptkbp:genericAvailable true
gptkbp:hasMolecularFormula C14H22ClN3O2
https://www.w3.org/2000/01/rdf-schema#label metoclopramide
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction 5-HT3 receptor antagonist
5-HT4 receptor agonist
D2 receptor antagonist
gptkbp:metabolism liver
gptkbp:pregnancyCategory B (US)
gptkbp:routeOfAdministration oral
intramuscular
intravenous
gptkbp:sideEffect diarrhea
fatigue
drowsiness
extrapyramidal symptoms
tardive dyskinesia
gptkbp:usedFor gptkb:gastroesophageal_reflux_disease
nausea
vomiting
gastroparesis
gptkbp:WHOModelListOfEssentialMedicines true
gptkbp:bfsParent gptkb:A04AA01
gptkbp:bfsLayer 6